Analysis of the Sweat Response According to the Pathology in Neurologic Patients
NCT ID: NCT03639909
Last Updated: 2018-08-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
450 participants
OBSERVATIONAL
2015-03-31
2017-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
CAN may be investigated by a battery of laboratory cardiovascular autonomic reflex tests(initially described by Ewing).
First screening for CAN (as proposed in diabetic patients) can be performed by assessing heart rate (HR) response to deep breathing, blood pressure (BP) and HR response to a 5 minutes stand test
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Risk Analysis for Diabetic Cardiovascular Autonomic Neuropathy
NCT02461472
Risk Analysis for Cardiovascular Autonomic Neuropathy
NCT02462616
Cardiac Autonomic Neuropathy in Patients With Metabolic Syndrome
NCT00907127
The Effect of α-lipoic Acid Treatment in Patient With Cardiac Autonomic Neuropathy
NCT02056366
Bayesian Estimation of Diagnostic Performance of Diabetic Cardiovascular Autonomic Neuropathy Without a Gold Standard
NCT02461381
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MSA-P
Patients with multiple systeme atrophy (MSA) with predominant parkinsonism (MSA-P) had evaluation of cardiovascular function and sweating function
sweating function
Sweating dysfunction by Sudoscan
Cardiovascular function
Cardiovascular (CV) tests
PD patients
Parkinson's disease (PD) patients had evaluation of cardiovascular function and sweating function
sweating function
Sweating dysfunction by Sudoscan
Cardiovascular function
Cardiovascular (CV) tests
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
sweating function
Sweating dysfunction by Sudoscan
Cardiovascular function
Cardiovascular (CV) tests
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Toulouse
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anne Pavy-Le Traon, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Toulouse
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RC31/15/7550
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.